BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32118791)

  • 21. Long-term evaluation of a fully magnetically levitated circulatory support device for advanced heart failure-two-year results from the HeartMate 3 CE Mark Study.
    Schmitto JD; Pya Y; Zimpfer D; Krabatsch T; Garbade J; Rao V; Morshuis M; Beyersdorf F; Marasco S; Sood P; Damme L; Netuka I
    Eur J Heart Fail; 2019 Jan; 21(1):90-97. PubMed ID: 30052304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heartmate 3 fully magnetically levitated left ventricular assist device for the treatment of advanced heart failure -1 year results from the Ce mark trial.
    Krabatsch T; Netuka I; Schmitto JD; Zimpfer D; Garbade J; Rao V; Morshuis M; Beyersdorf F; Marasco S; Damme L; Pya Y
    J Cardiothorac Surg; 2017 Apr; 12(1):23. PubMed ID: 28376837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. European experience of DuraHeart magnetically levitated centrifugal left ventricular assist system.
    Morshuis M; El-Banayosy A; Arusoglu L; Koerfer R; Hetzer R; Wieselthaler G; Pavie A; Nojiri C
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1020-7; discussion 1027-8. PubMed ID: 19233673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent pump thrombosis is common after axial continuous-flow left ventricular assist device exchange.
    Urban M; Um J; Moulton M; Stoller D; Zolty R; Lowes B; Macdonald C; McCain N; Siddique A
    Int J Artif Organs; 2020 Feb; 43(2):109-118. PubMed ID: 31530254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol.
    Heatley G; Sood P; Goldstein D; Uriel N; Cleveland J; Middlebrook D; Mehra MR;
    J Heart Lung Transplant; 2016 Apr; 35(4):528-36. PubMed ID: 27044532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lessons learned from the first fully magnetically levitated centrifugal LVAD trial in the United States: the DuraHeart trial.
    Moazami N; Steffen RJ; Naka Y; Jorde U; Bailey S; Murali S; Camacho MT; Zucker M; Marascalco PJ; Rao V; Feldman D;
    Ann Thorac Surg; 2014 Aug; 98(2):541-7. PubMed ID: 24928670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flow rate estimation of a centrifugal blood pump using the passively stabilized eccentric position of a magnetically levitated impeller.
    Shida S; Masuzawa T; Osa M
    Int J Artif Organs; 2019 Jun; 42(6):291-298. PubMed ID: 30854913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Physiology of Continuous-Flow Left Ventricular Assist Devices.
    Lim HS; Howell N; Ranasinghe A
    J Card Fail; 2017 Feb; 23(2):169-180. PubMed ID: 27989869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of Safety and Effectiveness of the Extracorporeal Continuous-Flow Ventricular Assist Device (BR16010) Use as a Bridge-to-Decision Therapy for Severe Heart Failure or Refractory Cardiogenic Shock: Study Protocol for Single-Arm Non-randomized, Uncontrolled, and Investigator-Initiated Clinical Trial.
    Fukushima N; Tatsumi E; Seguchi O; Takewa Y; Hamasaki T; Onda K; Yamamoto H; Hayashi T; Fujita T; Kobayashi J
    Cardiovasc Drugs Ther; 2018 Aug; 32(4):373-379. PubMed ID: 29948739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of low-intensity anti-coagulation with a fully magnetically levitated centrifugal-flow circulatory pump-the MAGENTUM 1 study.
    Netuka I; Ivák P; Tučanová Z; Gregor S; Szárszoi O; Sood P; Crandall D; Rimsans J; Connors JM; Mehra MR
    J Heart Lung Transplant; 2018 May; 37(5):579-586. PubMed ID: 29655662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left ventricular assist devices: A historical perspective at the intersection of medicine and engineering.
    Goodman D; Stulak J; Rosenbaum AN
    Artif Organs; 2022 Dec; 46(12):2343-2360. PubMed ID: 35929377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study.
    Colombo PC; Mehra MR; Goldstein DJ; Estep JD; Salerno C; Jorde UP; Cowger JA; Cleveland JC; Uriel N; Sayer G; Skipper ER; Downey FX; Ono M; Hooker R; Anyanwu AC; Givertz MM; Mahr C; Topuria I; Somo SI; Crandall DL; Horstmanshof DA
    Circulation; 2019 Jan; 139(2):155-168. PubMed ID: 30586698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-Term Outcomes of Magnetically Levitated Left Ventricular Assist Device in Advanced Heart Failure - The Japanese Cohort.
    Inoue K; Fujita T; Yoshioka D; Tonai K; Yanagino Y; Kakuta T; Tadokoro N; Kawamoto N; Yamashita K; Kawamura A; Matsuura R; Kawamura T; Saito T; Kawamura M; Kainuma S; Fukushima S; Toda K; Miyagawa S
    Circ J; 2022 Nov; 86(12):1961-1967. PubMed ID: 36273915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advanced heart failure: feasibility study of long-term continuous axial flow pump support.
    Siegenthaler MP; Westaby S; Frazier OH; Martin J; Banning A; Robson D; Pepper J; Poole-Wilson P; Beyersdorf F
    Eur Heart J; 2005 May; 26(10):1031-8. PubMed ID: 15800020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current axial-flow devices--the HeartMate II and Jarvik 2000 left ventricular assist devices.
    John R
    Semin Thorac Cardiovasc Surg; 2008; 20(3):264-72. PubMed ID: 19038737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous-Flow Left Ventricular Assist Device Survival Improves With Multidisciplinary Approach.
    Jorde UP; Shah AM; Sims DB; Madan S; Siddiqi N; Luke A; Saeed O; Patel SR; Murthy S; Shin J; Oviedo J; Watts S; Jakobleff W; Forest S; Vukelic S; Belov D; Puius Y; Minamoto G; Muggia V; Carlese A; Leung S; Rahmanian M; Leff J; Goldstein D
    Ann Thorac Surg; 2019 Aug; 108(2):508-516. PubMed ID: 30853587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Future devices and directions.
    Clark RE; Zafirelis Z
    Prog Cardiovasc Dis; 2000; 43(1):95-100. PubMed ID: 10935561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary results of long-term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist device implants.
    Mehra MR; Cleveland JC; Uriel N; Cowger JA; Hall S; Horstmanshof D; Naka Y; Salerno CT; Chuang J; Williams C; Goldstein DJ;
    Eur J Heart Fail; 2021 Aug; 23(8):1392-1400. PubMed ID: 33932272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of gravity on flow rate estimations of a centrifugal blood pump using the eccentric position of a levitated impeller.
    Shida S; Masuzawa T; Osa M
    Int J Artif Organs; 2020 Dec; 43(12):774-781. PubMed ID: 32393095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemocompatibility of Axial Versus Centrifugal Pump Technology in Mechanical Circulatory Support Devices.
    Schibilsky D; Lenglinger M; Avci-Adali M; Haller C; Walker T; Wendel HP; Schlensak C
    Artif Organs; 2015 Aug; 39(8):723-8. PubMed ID: 26234452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.